Key points are not available for this paper at this time.
The assessment of carcinogenic risk from very low doses of substances to which the population is exposed depends mainly on animal experiments. A variety of statistical models has been proposed for extrapolation to low doses from the much higher doses administered to animals. The most conservative approach uses a multistage model, and is almost equivalent to linear extrapolation. Cornfield has argued against a conservative approach, but linear extrapolation may also be close to the 'best' solution. Species conversion and specification of allowable risks are very difficult problems, and some form of cost-benefit analysis seems to be required.
P. Armitage (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: